Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials: a simulation study
非信息先验对随机试验中贝叶斯比例优势模型的影响AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要研究随机试验中治疗效应的贝叶斯估计及提前停止对结论的影响,因此归入因果推断。
非信息先验对随机试验中贝叶斯比例优势模型的影响AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Background: Ordinal outcomes combine multiple distinct ordered patient states into a single endpoint and are commonly analysed using proportional odds (PO) models in clinical trials. When using a Bayesian approach, it is not obvious what the influence of a 'non-informative' prior is in the analysis of a fixed design or on early stopping decisions in adaptive designs. Methods: This study compares different non-informative prior specifications for the Bayesian PO model in the context of both a two-arm trial with a fixed design and an adaptive design with an early stopping rule. We conducted an extensive simulation study, varying the effect size, sample size, number of categories and distribution of the control arm probabilities. Results: Our findings indicate that the choice of prior specification can introduce bias in the estimation of the treatment effect, particularly when control arm probabilities are right-skewed. The R-square prior specification resulted in the smallest bias and increased the likelihood of appropriately stopping early when there was a treatment effect. However, this specification exhibited larger biases when control arm probabilities were U-shaped when there was an early stopping rule. Dirichlet priors with concentration parameters close to zero resulted in the smallest bias when probabilities were right-skewed in the control arm, but were more likely to inappropriately stop early for superiority when there was no treatment effect and an early stopping rule. Conclusions: The specification of non-informative priors in Bayesian adaptive trials with ordinal outcomes has implications for treatment effect estimation and early stopping decisions. We recommend the careful selection of priors that consider the possible distribution of control arm probabilities and that sensitivity analyses to the prior be conducted.